Interactive Investor
>>

NovoCure Ltd (NASDAQ:NVCR) Share Price

NVCR

NovoCure Ltd

North American company

Right Arrow 1

Healthcare

Right Arrow 2

Medical Instruments & Supplies

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XNAS

-

Updated: -

Loading...

Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors.

NASDAQ:NVCR

JE00BYSS4X48

USD

Loading...

Loading Comparison

Latest NVCR News

Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News